Markets › India › NSE › AVIENCE

Avience Biomedicals Ltd

NSE:AVIENCEHealth Technology

₹258.10−3.30%At closeAt close · Mon 19 Oct · ≈ AED 9.97 · Market cap $14.89M

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	19.7%	19.7%	20.3%	23.8%	30.8%	33.7%	+2.9 pts
Operating margin	—	11.1%	11.2%	14.9%	23.5%	26.7%	+3.2 pts
Net margin	7.1%	7.1%	7.2%	9.0%	15.7%	16.7%	+1.0 pts
EBITDA margin	12.0%	12.0%	13.1%	17.5%	25.5%	29.0%	+3.6 pts
Return on equity	—	25.7%	19.2%	34.7%	31.3%	27.9%	−3.5 pts
Return on assets	11.8%	11.8%	7.8%	6.2%	12.6%	11.7%	−0.8 pts
Return on capital employed	—	37.5%	28.5%	25.8%	32.3%	31.1%	−1.2 pts
Debt / equity	—	0.9×	0.7×	2.4×	1.0×	0.9×	−5.8%
Debt / assets	40.8%	40.8%	26.5%	43.7%	39.2%	38.7%	−0.4 pts
Interest coverage	0.0×	7.0×	4.5×	3.8×	7.3×	8.3×	+13.0%
Current ratio	—	1.5×	1.2×	1.1×	1.6×	1.5×	−7.4%
Quick ratio	—	1.0×	0.5×	0.5×	1.0×	0.9×	−14.0%
Cash ratio	—	0.0×	0.0×	0.0×	0.2×	0.1×	−56.8%
Asset turnover	1.7×	1.7×	1.1×	0.7×	0.8×	0.7×	−12.1%
Inventory turnover	—	5.0×	2.2×	1.5×	2.4×	2.0×	−15.3%
Receivables turnover	—	4.0×	6.4×	2.9×	2.6×	2.5×	−5.1%
Dividend payout	—	0.0%	0.0%	0.0%	0.0%	0.0%	—